CLINICAL TRIAL / NCT05983770

Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

  • Interventional
  • Active
  • NCT05983770

AT-1501-K207: BESTOW: A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

This study will evaluate the safety and efficacy of AT-1501 compared with tacrolimus in patients undergoing kidney transplantation.